Foghorn Therapeutics (FHTX) Gains from Investment Securities (2020 - 2025)
Foghorn Therapeutics (FHTX) recorded quarterly Gains from Investment Securities of -$8000.0 in Q2 2025, down 100.66% quarter-over-quarter from $1.2 million in Q1 2025, and down 101.06% on a YoY basis from $754000.0 in Q2 2024.
Foghorn Therapeutics (FHTX) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Foghorn Therapeutics' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$8000.0 for Q2 2025.
- In Q2 2025, Gains from Investment Securities fell 101.06% year-over-year to -$8000.0; the TTM figure through Mar 2026 stood at -$8000.0 (down 100.66% YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
- Gains from Investment Securities was -$8000.0 for Q2 2025 at Foghorn Therapeutics, down from $1.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q2 2023 to a low of -$754000.0 in Q3 2024.
- Historically, Gains from Investment Securities has averaged $678714.3 across 3 years, with a median of $865000.0 in 2023.
- Biggest YoY gain for Gains from Investment Securities was 55.38% in 2024; the steepest drop was 175.7% in 2024.
- A 3-year view of Gains from Investment Securities shows it stood at $865000.0 in 2023, then sank by 187.17% to -$754000.0 in 2024, then jumped by 98.94% to -$8000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$8000.0 (Q2 2025), $1.2 million (Q1 2025), and -$754000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Foghorn Therapeutics | 282.33 Mn | 193.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Sep 30, 2024 | -754,000.00 |
| Sep 30, 2024 | -754,000.00 |
| Jun 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 754,000.00 |
| Dec 31, 2023 | 865,000.00 |
| Dec 31, 2023 | 865,000.00 |
| Sep 30, 2023 | 996,000.00 |
| Sep 30, 2023 | 996,000.00 |
| Jun 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Sep 30, 2020 | 70,000.00 |
| Sep 30, 2020 | 70,000.00 |
| Mar 31, 2020 | -1,000.00 |
| Mar 31, 2020 | -1,000.00 |